Global Influenza Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Influenza Diagnostics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Influenza Diagnostics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
  • 1.2.2 RIDT
  • 1.2.3 RT-PCR
  • 1.2.4 Cell Culture
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Influenza Diagnostics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
  • 1.3.2 Hospitals
  • 1.3.3 POCT
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Influenza Diagnostics Market Size Estimates and Forecasts
• 2.2 Influenza Diagnostics Market Size by Region: 2024 Versus 2031
  • 2.2.1 Global Influenza Diagnostics Revenue by Region: 2020-2025
  • 2.2.2 Global Influenza Diagnostics Revenue Forecast by Region (2026-2031)
  • 2.2.3 Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)

3 Market Segments

• 3.1 Breakdown Data by Type
  • 3.1.1 Global Influenza Diagnostics Revenue by Type (2020-2031)
  • 3.1.2 Global Influenza Diagnostics Revenue Market Share by Type (2020-2031)
• 3.2 Breakdown Data by Application
  • 3.2.1 Global Influenza Diagnostics Revenue by Application (2020-2031)
  • 3.2.2 Global Influenza Diagnostics Revenue Market Share by Application (2020-2031)
• 3.3 by Type and by Application Crossing Analysis
  • 3.3.1 RIDT of Influenza Diagnostics Revenue Market Share by Application
  • 3.3.2 RT-PCR of Influenza Diagnostics Revenue Market Share by Application
  • 3.3.3 Cell Culture of Influenza Diagnostics Revenue Market Share by Application
  • 3.3.4 Others of Influenza Diagnostics Revenue Market Share by Application

4 Global Influenza Diagnostics by Company

• 4.1 Global Influenza Diagnostics Revenue by Company (2020-2025)
• 4.2 Global Influenza Diagnostics Revenue Share by Company (2020-2025)
• 4.3 Competitive Landscape
  • 4.3.1 Key Influenza Diagnostics Companies around the World: Ranking by Revenue
  • 4.3.2 Global Influenza Diagnostics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
  • 4.3.3 Global Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.4 Global Influenza Diagnostics Companies Headquarters & Product Type
  • 4.4.1 Global Influenza Diagnostics Companies Headquarters
  • 4.4.2 Date of International Companies Enter into Influenza Diagnostics Market
  • 4.4.3 Global Influenza Diagnostics Companies Product & Service
  • 4.4.4 RIDT Revenue Market Share of Influenza Diagnostics by Company
  • 4.4.5 RT-PCR Revenue Market Share of Influenza Diagnostics by Company
  • 4.4.6 Cell Culture Revenue Market Share of Influenza Diagnostics by Company
  • 4.4.7 Others Revenue Market Share of Influenza Diagnostics by Company
• 4.5 Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans

5 Company Profiles

• 5.1 BD
  • 5.1.1 BD Corporation Information
  • 5.1.2 BD Description, Business Overview
  • 5.1.3 BD Influenza Diagnostics Products Offered
  • 5.1.4 BD Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.1.5 BD Influenza Diagnostics Revenue by Product in 2024
  • 5.1.6 BD Influenza Diagnostics Revenue by Application in 2024
  • 5.1.7 BD Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.1.8 BD Recent Developments
• 5.2 Abbott (Include Alere)
  • 5.2.1 Abbott (Include Alere) Corporation Information
  • 5.2.2 Abbott (Include Alere) Description, Business Overview
  • 5.2.3 Abbott (Include Alere) Influenza Diagnostics Products Offered
  • 5.2.4 Abbott (Include Alere) Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.2.5 Abbott (Include Alere) Influenza Diagnostics Revenue by Product in 2024
  • 5.2.6 Abbott (Include Alere) Influenza Diagnostics Revenue by Application in 2024
  • 5.2.7 Abbott (Include Alere) Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.2.8 Abbott (Include Alere) Recent Developments
• 5.3 Roche
  • 5.3.1 Roche Corporation Information
  • 5.3.2 Roche Description, Business Overview
  • 5.3.3 Roche Influenza Diagnostics Products Offered
  • 5.3.4 Roche Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.3.5 Roche Influenza Diagnostics Revenue by Product in 2024
  • 5.3.6 Roche Influenza Diagnostics Revenue by Application in 2024
  • 5.3.7 Roche Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.3.8 Roche Recent Developments
• 5.4 SIEMENS
  • 5.4.1 SIEMENS Corporation Information
  • 5.4.2 SIEMENS Description, Business Overview
  • 5.4.3 SIEMENS Influenza Diagnostics Products Offered
  • 5.4.4 SIEMENS Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.4.5 SIEMENS Influenza Diagnostics Revenue by Product in 2024
  • 5.4.6 SIEMENS Influenza Diagnostics Revenue by Application in 2024
  • 5.4.7 SIEMENS Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.4.8 SIEMENS Recent Developments
• 5.5 Analytik Jena
  • 5.5.1 Analytik Jena Corporation Information
  • 5.5.2 Analytik Jena Description, Business Overview
  • 5.5.3 Analytik Jena Influenza Diagnostics Products Offered
  • 5.5.4 Analytik Jena Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.5.5 Analytik Jena Influenza Diagnostics Revenue by Product in 2024
  • 5.5.6 Analytik Jena Influenza Diagnostics Revenue by Application in 2024
  • 5.5.7 Analytik Jena Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.5.8 Analytik Jena Recent Developments
• 5.6 Quidel
  • 5.6.1 Quidel Corporation Information
  • 5.6.2 Quidel Description, Business Overview
  • 5.6.3 Quidel Influenza Diagnostics Products Offered
  • 5.6.4 Quidel Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.6.5 Quidel Influenza Diagnostics Revenue by Product in 2024
  • 5.6.6 Quidel Influenza Diagnostics Revenue by Application in 2024
  • 5.6.7 Quidel Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.6.8 Quidel Recent Developments
• 5.7 Thermo Fisher
  • 5.7.1 Thermo Fisher Corporation Information
  • 5.7.2 Thermo Fisher Description, Business Overview
  • 5.7.3 Thermo Fisher Influenza Diagnostics Products Offered
  • 5.7.4 Thermo Fisher Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.7.5 Thermo Fisher Influenza Diagnostics Revenue by Product in 2024
  • 5.7.6 Thermo Fisher Influenza Diagnostics Revenue by Application in 2024
  • 5.7.7 Thermo Fisher Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.7.8 Thermo Fisher Recent Developments
• 5.8 Meridian Bioscience
  • 5.8.1 Meridian Bioscience Corporation Information
  • 5.8.2 Meridian Bioscience Description, Business Overview
  • 5.8.3 Meridian Bioscience Influenza Diagnostics Products Offered
  • 5.8.4 Meridian Bioscience Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.8.5 Meridian Bioscience Influenza Diagnostics Revenue by Product in 2024
  • 5.8.6 Meridian Bioscience Influenza Diagnostics Revenue by Application in 2024
  • 5.8.7 Meridian Bioscience Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.8.8 Meridian Bioscience Recent Developments
• 5.9 BioMerieux
  • 5.9.1 BioMerieux Corporation Information
  • 5.9.2 BioMerieux Description, Business Overview
  • 5.9.3 BioMerieux Influenza Diagnostics Products Offered
  • 5.9.4 BioMerieux Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.9.5 BioMerieux Influenza Diagnostics Revenue by Product in 2024
  • 5.9.6 BioMerieux Influenza Diagnostics Revenue by Application in 2024
  • 5.9.7 BioMerieux Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.9.8 BioMerieux Recent Developments
• 5.10 Sekisui Diagnostics
  • 5.10.1 Sekisui Diagnostics Corporation Information
  • 5.10.2 Sekisui Diagnostics Description, Business Overview
  • 5.10.3 Sekisui Diagnostics Influenza Diagnostics Products Offered
  • 5.10.4 Sekisui Diagnostics Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.10.5 Sekisui Diagnostics Influenza Diagnostics Revenue by Product in 2024
  • 5.10.6 Sekisui Diagnostics Influenza Diagnostics Revenue by Application in 2024
  • 5.10.7 Sekisui Diagnostics Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.10.8 Sekisui Diagnostics Recent Developments
• 5.11 Response Biomedical
  • 5.11.1 Response Biomedical Corporation Information
  • 5.11.2 Response Biomedical Description, Business Overview
  • 5.11.3 Response Biomedical Influenza Diagnostics Products Offered
  • 5.11.4 Response Biomedical Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.11.5 Response Biomedical Influenza Diagnostics Revenue by Product in 2024
  • 5.11.6 Response Biomedical Influenza Diagnostics Revenue by Application in 2024
  • 5.11.7 Response Biomedical Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.11.8 Response Biomedical Recent Developments
• 5.12 SA Scientific
  • 5.12.1 SA Scientific Corporation Information
  • 5.12.2 SA Scientific Description, Business Overview
  • 5.12.3 SA Scientific Influenza Diagnostics Products Offered
  • 5.12.4 SA Scientific Influenza Diagnostics Revenue and Gross Margin (2020-2025)
  • 5.12.5 SA Scientific Influenza Diagnostics Revenue by Product in 2024
  • 5.12.6 SA Scientific Influenza Diagnostics Revenue by Application in 2024
  • 5.12.7 SA Scientific Influenza Diagnostics Revenue by Geographic Area in 2024
  • 5.12.8 SA Scientific Recent Developments

6 North America

• 6.1 North America Influenza Diagnostics Market Size YoY Growth 2020-2031
• 6.2 North America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
• 6.3 North America Influenza Diagnostics Revenue by Type (2020-2025)
• 6.4 North America Influenza Diagnostics Revenue by Application (2020-2025)

7 Asia-Pacific

• 7.1 Asia-Pacific Influenza Diagnostics Market Size YoY Growth 2020-2031
• 7.2 Asia-Pacific Influenza Diagnostics Market Facts & Figures by Region (2020-2031)
• 7.3 Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025)
• 7.4 Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025)

8 Europe

• 8.1 Europe Influenza Diagnostics Market Size YoY Growth 2020-2031
• 8.2 Europe Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
• 8.3 Europe Influenza Diagnostics Revenue by Type (2020-2025)
• 8.4 Europe Influenza Diagnostics Revenue by Application (2020-2025)

9 Latin America

• 9.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
• 9.2 Latin America Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
• 9.3 Latin America Influenza Diagnostics Revenue by Type (2020-2025)
• 9.4 Latin America Influenza Diagnostics Revenue by Application (2020-2025)

10 Middle East and Africa

• 10.1 Latin America Influenza Diagnostics Market Size YoY Growth 2020-2031
• 10.2 Middle East and Africa Influenza Diagnostics Market Facts & Figures by Country (2020-2031)
• 10.3 Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025)
• 10.4 Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

• 11.1 Influenza Diagnostics Supply Chain Analysis
• 11.2 Influenza Diagnostics Key Raw Materials and Upstream Suppliers
• 11.3 Influenza Diagnostics Clients Analysis
• 11.4 Influenza Diagnostics Sales Channel and Sales Model Analysis
  • 11.4.1 Influenza Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 11.4.2 Influenza Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
  • 11.4.3 Influenza Diagnostics Distributors

12 Influenza Diagnostics Market Dynamics

• 12.1 Influenza Diagnostics Industry Trends
• 12.2 Influenza Diagnostics Market Drivers
• 12.3 Influenza Diagnostics Market Challenges
• 12.4 Influenza Diagnostics Market Restraints

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details
• 14.3 Disclaimer

List of Tables

Table 1. Global Influenza Diagnostics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Influenza Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Influenza Diagnostics Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Influenza Diagnostics Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 6. Global Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 7. Global Influenza Diagnostics Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 8. Global Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 9. Global Influenza Diagnostics Revenue Forecast by Application (2026-2031) & (US$ Million)

Table 10. Influenza Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 11. Influenza Diagnostics Revenue Share by Company (2020-2025)

Table 12. Ranking of Global Top Influenza Diagnostics Players by Revenue (US$ Million) in 2024

Table 13. Global Influenza Diagnostics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 14. Global Influenza Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Diagnostics as of 2024)

Table 15. Global Influenza Diagnostics Companies Headquarters

Table 16. Date of International Companies Enter into Influenza Diagnostics Market

Table 17. Global Influenza Diagnostics Companies Product & Service

Table 18. Global Influenza Diagnostics Mergers & Acquisitions, Expansion Plans

Table 19. BD Corporation Information

Table 20. BD Description and Business Overview

Table 21. BD Influenza Diagnostics Product

Table 22. BD Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 23. BD Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 24. BD Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 25. BD Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 26. BD Recent Developments

Table 27. Abbott (Include Alere) Corporation Information

Table 28. Abbott (Include Alere) Description and Business Overview

Table 29. Abbott (Include Alere) Influenza Diagnostics Product

Table 30. Abbott (Include Alere) Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 31. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 32. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 33. Abbott (Include Alere) Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 34. Abbott (Include Alere) Recent Developments

Table 35. Roche Corporation Information

Table 36. Roche Description and Business Overview

Table 37. Roche Influenza Diagnostics Product

Table 38. Roche Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 39. Roche Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 40. Roche Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 41. Roche Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 42. Roche Recent Developments

Table 43. SIEMENS Corporation Information

Table 44. SIEMENS Description and Business Overview

Table 45. SIEMENS Influenza Diagnostics Product

Table 46. SIEMENS Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. SIEMENS Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 48. SIEMENS Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 49. SIEMENS Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 50. SIEMENS Recent Developments

Table 51. Analytik Jena Corporation Information

Table 52. Analytik Jena Description and Business Overview

Table 53. Analytik Jena Influenza Diagnostics Product

Table 54. Analytik Jena Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 55. Analytik Jena Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 56. Analytik Jena Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 57. Analytik Jena Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 58. Analytik Jena Recent Developments

Table 59. Quidel Corporation Information

Table 60. Quidel Description and Business Overview

Table 61. Quidel Influenza Diagnostics Product

Table 62. Quidel Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 63. Quidel Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 64. Quidel Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 65. Quidel Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 66. Quidel Recent Developments

Table 67. Thermo Fisher Corporation Information

Table 68. Thermo Fisher Description and Business Overview

Table 69. Thermo Fisher Influenza Diagnostics Product

Table 70. Thermo Fisher Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 71. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 72. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 73. Thermo Fisher Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 74. Thermo Fisher Recent Developments

Table 75. Meridian Bioscience Corporation Information

Table 76. Meridian Bioscience Description and Business Overview

Table 77. Meridian Bioscience Influenza Diagnostics Product

Table 78. Meridian Bioscience Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 79. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 80. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 81. Meridian Bioscience Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 82. Meridian Bioscience Recent Developments

Table 83. BioMerieux Corporation Information

Table 84. BioMerieux Description and Business Overview

Table 85. BioMerieux Influenza Diagnostics Product

Table 86. BioMerieux Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 87. BioMerieux Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 88. BioMerieux Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 89. BioMerieux Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 90. BioMerieux Recent Developments

Table 91. Sekisui Diagnostics Corporation Information

Table 92. Sekisui Diagnostics Description and Business Overview

Table 93. Sekisui Diagnostics Influenza Diagnostics Product

Table 94. Sekisui Diagnostics Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 95. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 96. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 97. Sekisui Diagnostics Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 98. Sekisui Diagnostics Recent Developments

Table 99. Response Biomedical Corporation Information

Table 100. Response Biomedical Description and Business Overview

Table 101. Response Biomedical Influenza Diagnostics Product

Table 102. Response Biomedical Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Response Biomedical Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 104. Response Biomedical Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 105. Response Biomedical Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 106. Response Biomedical Recent Developments

Table 107. SA Scientific Corporation Information

Table 108. SA Scientific Description and Business Overview

Table 109. SA Scientific Influenza Diagnostics Product

Table 110. SA Scientific Influenza Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 111. SA Scientific Revenue Proportion of Influenza Diagnostics by Product in 2024

Table 112. SA Scientific Revenue Proportion of Influenza Diagnostics by Application in 2024

Table 113. SA Scientific Revenue Proportion of Influenza Diagnostics by Geographic Area in 2024

Table 114. SA Scientific Recent Developments

Table 115. North America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)

Table 116. North America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)

Table 117. North America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 118. North America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 119. Asia-Pacific Influenza Diagnostics Revenue by Region (2020-2025) & (US$ Million)

Table 120. Asia-Pacific Influenza Diagnostics Revenue by Region (2026-2031) & (US$ Million)

Table 121. Asia-Pacific Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 122. Asia-Pacific Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 123. Europe Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)

Table 124. Europe Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)

Table 125. Europe Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 126. Europe Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 127. Latin America Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)

Table 128. Latin America Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)

Table 129. Latin America Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 130. Latin America Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 131. Middle East and Africa Influenza Diagnostics Revenue by Country (2020-2025) & (US$ Million)

Table 132. Middle East and Africa Influenza Diagnostics Revenue by Country (2026-2031) & (US$ Million)

Table 133. Middle East and Africa Influenza Diagnostics Revenue by Type (2020-2025) & (US$ Million)

Table 134. Middle East and Africa Influenza Diagnostics Revenue by Application (2020-2025) & (US$ Million)

Table 135. Influenza Diagnostics Key Raw Materials, Industry Status and Trend

Table 136. Influenza Diagnostics Key Raw Materials and Upstream Suppliers

Table 137. Influenza Diagnostics Clients Status and Trend

Table 138. Influenza Diagnostics Typical Clients

Table 139. Influenza Diagnostics Distributors

Table 140. Influenza Diagnostics Market Trends

Table 141. Influenza Diagnostics Market Drivers

Table 142. Influenza Diagnostics Market Challenges

Table 143. Influenza Diagnostics Market Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza Diagnostics Product Picture

Figure 2. Global Influenza Diagnostics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Influenza Diagnostics Revenue Market Share by Type in 2024 & 2031

Figure 4. RIDT Product Picture

Figure 5. RT-PCR Product Picture

Figure 6. Cell Culture Product Picture

Figure 7. Others Product Picture

Figure 8. Global Influenza Diagnostics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Influenza Diagnostics Revenue Market Share by Application in 2024 & 2031

Figure 10. Hospitals

Figure 11. POCT

Figure 12. Others

Figure 13. Influenza Diagnostics Report Years Considered

Figure 14. Global Influenza Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Influenza Diagnostics Market Size (2020-2031) & (US$ Million)

Figure 16. Global Influenza Diagnostics Market Size Market Share by Region: 2024 Versus 2031

Figure 17. Global Influenza Diagnostics Revenue Market Share by Region (2020-2031)

Figure 18. Global Influenza Diagnostics Revenue Market Share Forecast by Type (2020-2031)

Figure 19. Global Influenza Diagnostics Revenue Market Share Forecast by Application (2020-2031)

Figure 20. RIDT of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031

Figure 21. RT-PCR of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031

Figure 22. Cell Culture of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031

Figure 23. Others of Influenza Diagnostics Revenue Market Share by Application, 2024 VS 2031

Figure 24. Influenza Diagnostics Revenue Share by Company (2024)

Figure 25. Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 26. RIDT Revenue Proportion by Company in 2024

Figure 27. RT-PCR Revenue Proportion by Company in 2024

Figure 28. Cell Culture Revenue Proportion by Company in 2024

Figure 29. Others Revenue Proportion by Company in 2024

Figure 30. North America Influenza Diagnostics Revenue 2020-2031 (US$ Million)

Figure 31. North America Influenza Diagnostics Revenue Market Share by Type (2020-2025)

Figure 32. North America Influenza Diagnostics Revenue Market Share by Application (2020-2025)

Figure 33. Asia-Pacific Influenza Diagnostics Revenue 2020-2031 (US$ Million)

Figure 34. Asia-Pacific Influenza Diagnostics Revenue Market Share by Region (2020-2031)

Figure 35. Asia-Pacific Influenza Diagnostics Revenue Market Share by Type (2020-2025)

Figure 36. Asia-Pacific Influenza Diagnostics Revenue Market Share by Application (2020-2025)

Figure 37. Europe Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 38. Europe Influenza Diagnostics Revenue Market Share by Country (2020-2031)

Figure 39. Europe Influenza Diagnostics Revenue Market Share by Type (2020-2025)

Figure 40. Europe Influenza Diagnostics Revenue Market Share by Application (2020-2025)

Figure 41. Latin America Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 42. Latin America Influenza Diagnostics Revenue Market Share by Country (2020-2031)

Figure 43. Latin America Influenza Diagnostics Revenue Market Share by Type (2020-2025)

Figure 44. Latin America Influenza Diagnostics Revenue Market Share by Application (2020-2025)

Figure 45. Middle East and Africa Influenza Diagnostics Revenue Growth Rate 2020-2031 (US$ Million)

Figure 46. Middle East and Africa Influenza Diagnostics Revenue Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Influenza Diagnostics Revenue Market Share by Type (2020-2025)

Figure 48. Middle East and Africa Influenza Diagnostics Revenue Market Share by Application (2020-2025)

Figure 49. Influenza Diagnostics Supply Chain (Upstream and Downstream Market)

Figure 50. Global Production Market Share of Influenza Diagnostics Raw Materials by Region in 2024

Figure 51. Influenza Diagnostics Distribution Channels

Figure 52. Global Influenza Diagnostics Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 53. Global Influenza Diagnostics Percentage 2020-2031: Online Sales VS Offline Sales

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed